Probiotic Blister: Out of Specification

Dernière mise à jour

2023-03-01

Summary

Produit

Probiotic Blister

Problème

Health products - Product quality

Ce qu’il faut faire

Consult your health care professional if you have any health concerns.

Brand	Product Name	Market Authorization	Dosage Form	Strength	Lot
Probiotic Blister	Probiotic 50 billion	NPN 80083913	Capsule	Bifidobacterium animalis subsp. lactis 15 billion CFU, Bifidobacterium bifidum 1 billion CFU, Bifidobacterium longum subsp. longum 1.5 billion CFU, Lacticaseibacillus paracasei 2.5 billion CFU, Lactiplantibacillus plantarum 2.5 billion CFU, Lactobacillus acidophilus 2.5 billion CFU, Lactobacillus casei 2 billion CFU, Lactobacillus gasseri 2.5 billion CFU, Lactobacillus reuteri 0.5 billion CFU, Lactobacillus rhamnosus 20 billion CF	VA269

Bacteria content is below specification in the affected lot.

Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.

Contexte

Depth of recall: Retailers

Details

Original published date: 2023-03-01

Type d’avis ou de rappel

Health product recall

Catégorie

Health product - Natural health products

Entreprises

Jamp Pharma Corporation
1310 Rue Nobel
Boucherville, QC J4B 5H3

Published by

Health Canada

Audience

General public

Healthcare

Industry

Classe de rappel

Type II

Identification number

RA-73064